Sir, Resistance to carbapenems in Klebsiella pneumoniae has become a major concern worldwide, which is almost exclusively associated with healthcare settings. New Delhi metallo-b-lactamases (NDMs) are carbapenem-hydrolysing enzymes first identified in K. pneumoniae in 2008 in a Swedish patient previously hospitalized in India.
Sir, Resistance to carbapenems in Klebsiella pneumoniae has become a major concern worldwide, which is almost exclusively associated with healthcare settings. New Delhi metallo-b-lactamases (NDMs) are carbapenem-hydrolysing enzymes first identified in K. pneumoniae in 2008 in a Swedish patient previously hospitalized in India. 1 The Indian subcontinent remains the major reservoir of NDM producers, but they have now disseminated widely. To date, 16 NDM variants have been identified with NDM-1 being the most prevalent. In Tunisia, no autochthonous NDM-1-producing Enterobacteriaceae has been reported yet, even though its presence was suspected twice. Indeed, one study reported NDM-1-producing Enterobacteriaceae in Polish tourists that had been hospitalized in Tunis and a second reported an NDM-1-producing K. pneumoniae in a Libyan woman hospitalized in Tunis. 2, 3 Our goal was to clarify the presence and spread of NDM producers in Tunisia, to ascertain their prevalence in hospitals and to characterize the strains molecularly.
A retrospective study was conducted in two university hospitals between 2013 and 2015. A large collection of 241 and 46 carbapenem-resistant K. pneumoniae (CKP) isolates were recovered from clinical specimens of hospitalized patients in Sahloul Hospital in Sousse and Tahar Sfar Hospital in Mahdia, respectively. Seventeen of 241 (7%) and 2 of 46 (4.5%) CKP tested positive using the Total Metallo-b-Lactamase (MBL) Confirm Kit (ROSCO, Taastrup, Denmark), modified Hodge test, Carba NP test and EDTA double-disc synergy test (Table 1) . In addition to all b-lactams including carbapenems (ertapenem, meropenem and imipenem, MICs .32 mg/L), all isolates were resistant to aminoglycosides (kanamycin, gentamicin, tobramycin and netilmicin), tetracyclines, sulphonamides and trimethoprim, nalidixic acid and ciprofloxacin, but were susceptible to amikacin, colistin and tigecycline. Of note, considering the nature of the antibiotic treatments prescribed (Table 1) , recovery probably resulted from the fact that most patients were colonized rather than infected by CKP.
PCR and sequencing for the bla VIM , bla IMP , bla NDM-like , bla OXA-48-like , bla KPC , bla CTX-M , bla TEM and bla CMY genes revealed that all isolates possessed the bla NDM-1 and bla CTX-M-15 genes, with one isolate (S17) coharbouring bla OXA-48 and bla NDM-1 together with bla CTX-M-15 . 4 The bla NDM-1 gene was carried by an IncFIIk plasmid in all isolates, as proved by PCR-based replicon typing (Diatheva, Fano, Italy), S1-PFGE and hybridization with adequate probes. As shown by PCR mapping, for all isolates, bla NDM-1 was located inside a Tn125 transposon presenting the same genetic organization as the one reported by Izdebski et al.
3 for NDM-1-producing isolates potentially originating from Tunisia. 5, 6 Indeed, the Tn125 element comprised the 3 ′ part of the upstream ISAba125 element, the bla NDM-1 , ble MBL , iso, tat, dct, groES and groEL genes and was then truncated after the groEL gene. In isolate S17, the bla OXA-48 gene was carried by an IncL plasmid. The bla OXA-48 gene was located in a Tn1999.2 transposon as revealed by a disruption of the upstream IS1999 element by IS1R using PCR mapping. Clonality was assessed by XbaI-PFGE and 17 isolates presented identical profiles, while 2 isolates presented a highly similar profile with only one band difference. MLST carried out according to the protocol described on the K. pneumoniae MLST web site (http://bigsdb.web.pasteur.fr/) revealed that they all belonged to ST147. No transfer of patients had occurred between the two hospitals and no hospital staff was shared either. Consequently, a direct transmission of this NDM-1-producing ST147 K. pneumoniae clone between those hospitals in two different cities is unlikely. Interestingly, while the first NDM-1-producing K. pneumoniae isolated from a Libyan woman in Tunis in 2012 belonged to ST11, 2 the two Polish patients transiently hospitalized in Tunis in 2015 after a terrorist attack both carried an ST147 NDM-1-producing K. pneumoniae. Thus, our data are in line with the hypothesis of Izdebski et al. 3 suggesting a Tunisian origin of these cases. In Tunisia, ST147 K. pneumoniae was recently reported to disseminate the OXA-204 enzyme, an OXA-48 derivative. 8 Here, all recent Tunisian cases of NDM-1-producing K. pneumoniae also belonged to ST147, which strongly argues for the epidemic success of this clone in Tunisia. Of note, one NDM-1-positive ST147 K. pneumoniae isolate also produced OXA-48. This shows that the successful spread of an NDM-1-producing K. pneumoniae clone in a country where OXA-48 enzymes are endemic may lead to the emergence of K. pneumoniae isolates carrying several carbapenem resistance determinants. The origin of NDM enzymes in Tunisia cannot be reliably traced. It could result from the huge number of Libyan refugees transferred to the Sahloul and Taher Sfar university hospitals after the revolution of 2012. However, Libyan refugees were mostly reported to be colonized with OXA-48 (and not NDM-1) producers. On the other hand, a common Tunisian origin of the two outbreaks is also plausible, which would have remained undetected until recently. In Tunisia as in other North African countries, resistance to carbapenems in K. pneumoniae was mostly associated with the spread of the OXA-48-producing ST101 clone. 8, 9 Here, in two Tunisian hospitals, we report the spread of the NDM-1-producing ST147 K. pneumoniae clone. Interestingly, the ST147 K. pneumoniae clone has been reported in several Mediterranean countries and worldwide, spreading different resistance traits including NDM-type, OXA-48 or OXA-204 enzymes. Nosocomial infections by CKP are associated with high rates of morbidity and mortality. Rapid identification of the MBL-producing bacteria is crucial to adapt the treatments appropriately and to set up control measures in hospitals, especially regarding foreign patients. Our data indicate that the dissemination of NDM-1-producing K. pneumoniae in Tunisia may be underestimated both in clinical settings and the community, where specific hygiene and preventive programmes should be implemented urgently. 
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